CATX Stock Analysis: Buy, Sell, or Hold?
CATX - Perspective Therapeutics, Inc.
$3.56
-0.04 (-1.11%)
▼
5d:
-14.42%
30d:
-10.55%
90d:
-32.45%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When CATX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CATX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CATX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CATX is currently trading at $3.56, which is considered oversold relative to its 30-day fair value range of $3.70 to $4.15.
Technical Outlook: Technically, CATX is showing sideways momentum. The price is currently testing key support at $3.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CATX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.93 (+263.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CATX is showing sideways momentum. The price is currently testing key support at $3.53. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CATX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.93 (+263.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.70 -
$4.15
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 263.3% below Wall St target ($12.93)
- CAUTION: 5-day price weakness (-14.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.70 -
$4.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.53
Resistance Level
$4.34
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.09
Wall Street Target
$12.93
(+263.3%)
Revenue Growth (YoY)
-77.8%
Share & Embed Analysis
Last updated: June 03, 2026 8:14 PM ET
Data refreshes hourly during market hours. Next update: 9:14 PM
Data refreshes hourly during market hours. Next update: 9:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CATX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$83 | 54 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$82 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 64 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$107 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 59 HOLD |
